FDA Brief

Warning letters Drugs

FDA warning letter to

Cheap Medicine Shop/www.cheapmedicineshop.com

High riskIssued Sep 24Posted Oct 6Center for Drug Evaluation and Research (CDER)

FDA warned India-based website Cheap Medicine Shop for selling unapproved, misbranded injectable semaglutide to U.S. consumers.

What happened

FDA reviewed the website www.cheapmedicineshop.com on August 26, 2026 and September 2, 2026, and found it offering a semaglutide injection marketed as "Semanext Injection" for sale to U.S. consumers. The site claims the product is a weekly injectable used to control blood sugar in adults and to support weight loss and obesity management. FDA says there is no approved application for this product and its labeling lacks adequate directions for use.

What FDA found

  1. The company sells a semaglutide injection that FDA has not approved.

    FD&C Act sections 301(d) and 505(a) (21 U.S.C. 355(a))
  2. The product's labeling does not give adequate directions for use, which is required for a prescription drug.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))
  3. The drug is a prescription product that is not safe for laypeople to use without a licensed practitioner's supervision.

    FD&C Act section 503(b)(1) (21 U.S.C. 353(b)(1))
  4. Offering the misbranded drug for sale to U.S. consumers puts it into interstate commerce illegally.

    FD&C Act section 301(a) (21 U.S.C. 331(a))
  5. The product is not exempt from the adequate-directions requirement because it is not approved in the United States.

    21 CFR 201.115(a)

What FDA wants

FDA requests that the website stop offering unapproved and misbranded drugs for sale to U.S. consumers. The company must send a written response with corrective steps and supporting documents within 15 business days of receiving the letter, citing reference MARCS-CMS 737810.

Who should pay attention

  • U.S. consumers who buy prescription drugs from overseas websites
  • legitimate online pharmacies and telehealth prescribers of semaglutide
  • quality and compliance teams at drug distributors and importers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk